Care365.caYour health is one click away
Menu
Vaccine product guide

VAXNEUVANCE

Pneumococcal 15-valent conjugate (Pneu-C-15) · Pneumococcal

Health Canada DIN 02522403. Check the product and formulation on your record before using a schedule.

Plan doses for this product →
DIN
02522403
Family
Pneumococcal
Guidance checked
2026-09-27
← All Pneumococcal products

About this vaccine

Vaxneuvance is a vaccine that helps protect you or your child against serious infections caused by a common type of bacteria called pneumococcus.

VAXNEUVANCE is listed under Health Canada DIN 02522403. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.

At a glance

Brand
VAXNEUVANCE
DIN
02522403
Vaccine
Pneumococcal 15-valent conjugate (Pneu-C-15)
Presentation
0.5 mL · suspension · intramuscular · 6 weeks and older
Live vaccine
No

Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.

Official sources

Use the DIN to confirm this exact product in Health Canada's Drug Product Database.

Health CanadaMonograph PDF

A listed product may not be stocked or publicly funded.

Before and after your vaccination

  • Bring your immunization record if you have one, so earlier doses can be checked.
  • Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
  • After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
  • Keep a record of the vaccine name, date and dose you received.

These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.

Practical guidance for VAXNEUVANCE

The details below are adapted from a Pharmasist patient handout linked to the same product monograph. The current Canadian Immunization Guide determines the dose schedules shown later.

What this vaccine helps prevent

  • Vaxneuvance is a vaccine that helps protect you or your child against serious infections caused by a common type of bacteria called pneumococcus.
  • It can help prevent infections like pneumonia, meningitis, and blood infections caused by 15 different strains of this bacteria.
  • It does not protect against every strain of pneumococcus, or against other germs that can cause similar illnesses.

What to mention before a dose

  • Tell the person giving the vaccine if you or your child has ever had a severe allergic reaction to a previous dose of this vaccine or to any vaccine that contains diphtheria toxoid.
  • Tell them if you or your child has a bleeding problem or is taking blood thinners.
  • Tell them if you or your child has a weakened immune system, from an illness or from medicine, since the vaccine may work less well in this case.
  • Tell them if you or your child is currently sick with a fever, since vaccination may need to be delayed.

How it is given

  • Vaxneuvance is given as a shot into a muscle, usually in the upper arm for adults and children, or the thigh for infants.
  • It is given by a doctor, nurse, or healthcare professional, not something you give yourself at home.

Important things to know

  • Like any vaccine, Vaxneuvance can rarely cause a serious allergic reaction, usually within minutes of the injection.
  • Fainting can happen after any vaccination, especially in teenagers and young adults. You will usually be asked to sit or lie down and wait for about 15 minutes after your shot so this can be caught early.
  • This vaccine does not protect against every case of pneumococcal infection, so continue to seek medical care for symptoms of infection even after vaccination.

Effects you may notice

  • Pain, redness, or swelling where the shot was given.
  • Feeling tired.
  • Headache.
  • Sore muscles or joints.
  • In babies and toddlers: fussiness, sleepiness, or not wanting to eat as much as usual.
  • A mild fever.
  • Hives, an itchy raised rash, have been seen in some children.

When to contact a healthcare professional

  • Contact your provider if the injection site becomes very swollen, very red, or does not improve after a few days.
  • Contact your provider if a fever is high or does not go away.
  • Contact your provider about any side effect that worries you or does not go away.

When to get emergency help

  • Get help right away for signs of a severe allergic reaction, such as swelling of the face, lips, or throat, trouble breathing, a fast heartbeat, or a widespread rash.
  • Get help right away for fainting that leads to a fall or injury.

Other medicines and vaccines

  • This vaccine is given by injection, not by mouth, so food and alcohol are not expected to affect it.
  • Tell your provider about any medicines that weaken the immune system, such as steroids or cancer treatments, since these can make the vaccine less effective.
  • This vaccine can usually be given at the same visit as other vaccines, using a separate needle and a different injection site.

Key points to remember

  • Bring your or your child's immunization record to every vaccine visit so it can be kept up to date.
  • Tell every healthcare provider you see about all the vaccines you or your child have received.
  • Watch the injection site and your overall feeling of wellness for a few days after vaccination, and contact your provider with any concerns.

The practical points are adapted from the Pharmasist reference for VAXNEUVANCE and its matching product monograph.

Dose schedules

These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.

Pneumococcal conjugate — healthy infant, three doses (2 + 1)

3 doses

Two doses at 2 and 4 months plus a booster at 12 months.

Routine schedule for healthy infants in provinces using a 2 + 1 series, including Ontario: doses at 2 and 4 months, then a booster at 12 months of age. Minimum 8 weeks between doses; the booster is not given before 12 months of age. Infants with risk factors need the four-dose (3 + 1) schedule.

Pneumococcal conjugate — higher-risk infant, four doses (3 + 1)

4 doses

Three doses at 2, 4 and 6 months plus a booster at 12 to 15 months.

For infants with immunocompromising conditions, chronic heart, lung, kidney or liver disease, cochlear implants, CSF leak, sickle cell disease or asplenia, and premature infants: doses at 2, 4 and 6 months followed by a booster at 12 to 15 months. Minimum 8 weeks between doses; the booster is not given before 12 months of age.

Check your dose plan →

Pregnancy and breastfeeding

Family guidance on pregnancy: Recommended for people at high risk of pneumococcal disease.

Family guidance on breastfeeding: Recommended for people at high risk of pneumococcal disease.

This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.

References and product information

General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.

Explore care options